期刊文献+
共找到328篇文章
< 1 2 17 >
每页显示 20 50 100
Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells 被引量:8
1
作者 Kai-Ling Huang Yiu-Kay Lai +1 位作者 Chih-Chien Lin Jia-Ming Chang 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第35期5721-5725,共5页
AIM: To explore the anti-hepatitis B virus (HBV) effects of Boehmeria nivea (B. nivea) root extract (BNE) by using the HepG2 2.2.15 cell model system. METHODS: Hepatitis B surface antigen (HBsAg), hepatitis B virus e ... AIM: To explore the anti-hepatitis B virus (HBV) effects of Boehmeria nivea (B. nivea) root extract (BNE) by using the HepG2 2.2.15 cell model system. METHODS: Hepatitis B surface antigen (HBsAg), hepatitis B virus e antigen (HBeAg), and HBV DNA were measured by using ELISA and real-time PCR, respectively. Viral DNA replication and RNA expression were determined by using Southern and Northern blot, respectively. RESULTS: In HepG2 2.2.15 cells, HBeAg (60%, P < 0.01) and particle-associated HBV DNA (> 99%, P < 0.01) secretion into supernatant were significantly inhibited by BNE at a dose of 100 mg/L, whereas the HBsAg was not inhibited. With different doses of BNE, the reduced HBeAg was correlated with the inhibition of HBV DNA. The anti-HBV effect of BNE was not caused by its cytotoxicity to cells or inhibition of viral DNA replication and RNA expression. CONCLUSION: BNE could effectively reduce the HBV production and its anti-HBV machinery might differ from the nucleoside analogues. 展开更多
关键词 Boehmeria nivea Medicinal herb Antiviral agent Hepatitis B virus Anti-hepatitis B virus hepg2 2.2.15
下载PDF
HepG2.2.15-derived exosomes facilitate the activation and fibrosis of hepatic stellate cells
2
作者 Yang Gao Li Li +3 位作者 Sheng-Ning Zhang Yuan-Yi Mang Xi-Bing Zhang Shi-Ming Feng 《World Journal of Gastroenterology》 SCIE CAS 2024年第19期2553-2563,共11页
BACKGROUND The role of exosomes derived from HepG2.2.15 cells,which express hepatitis B virus(HBV)-related proteins,in triggering the activation of LX2 liver stellate cells and promoting liver fibrosis and cell prolif... BACKGROUND The role of exosomes derived from HepG2.2.15 cells,which express hepatitis B virus(HBV)-related proteins,in triggering the activation of LX2 liver stellate cells and promoting liver fibrosis and cell proliferation remains elusive.The focus was on comprehending the relationship and influence of differentially expressed microRNAs(DE-miRNAs)within these exosomes.AIM To elucidate the effect of exosomes derived from HepG2.2.15 cells on the activation of hepatic stellate cell(HSC)LX2 and the progression of liver fibrosis.METHODS Exosomes from HepG2.2.15 cells,which express HBV-related proteins,were isolated from parental HepG2 and WRL68 cells.Western blotting was used to confirm the presence of the exosomal marker protein CD9.The activation of HSCs was assessed using oil red staining,whereas DiI staining facilitated the observation of exosomal uptake by LX2 cells.Additionally,we evaluated LX2 cell proliferation and fibrosis marker expression using 5-ethynyl-2′-deoxyuracil staining and western blotting,respectively.DE-miRNAs were analyzed using DESeq2.Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathways were used to annotate the target genes of DE-miRNAs.RESULTS Exosomes from HepG2.2.15 cells were found to induced activation and enhanced proliferation and fibrosis in LX2 cells.A total of 27 miRNAs were differentially expressed in exosomes from HepG2.2.15 cells.GO analysis indicated that these DE-miRNA target genes were associated with cell differentiation,intracellular signal transduction,negative regulation of apoptosis,extracellular exosomes,and RNA binding.KEGG pathway analysis highlighted ubiquitin-mediated proteolysis,the MAPK signaling pathway,viral carcinogenesis,and the toll-like receptor signaling pathway,among others,as enriched in these targets.CONCLUSION These findings suggest that exosomes from HepG2.2.15 cells play a substantial role in the activation,proliferation,and fibrosis of LX2 cells and that DE-miRNAs within these exosomes contribute to the underlying mechanisms. 展开更多
关键词 Hepatic stellate cells Liver fibrosis EXOSOMES Small RNA sequencing HEPG2.2.15
下载PDF
Evaluation of the intracellular lipid-lowering effect of polyphenols extract from highland barley in HepG2 cells 被引量:3
3
作者 Yijun Yao Zhifang Li +2 位作者 Bowen Qin Xingrong Ju Lifeng Wang 《Food Science and Human Wellness》 SCIE CSCD 2024年第1期454-461,共8页
Active ingredients from highland barley have received considerable attention as natural products for developing treatments and dietary supplements against obesity.In practical application,the research of food combinat... Active ingredients from highland barley have received considerable attention as natural products for developing treatments and dietary supplements against obesity.In practical application,the research of food combinations is more significant than a specific food component.This study investigated the lipid-lowering effect of highland barley polyphenols via lipase assay in vitro and HepG2 cells induced by oleic acid(OA).Five indexes,triglyceride(TG),total cholesterol(T-CHO),low density lipoprotein-cholesterol(LDL-C),aspartate aminotransferase(AST),and alanine aminotransferase(ALT),were used to evaluate the lipidlowering effect of highland barley extract.We also preliminary studied the lipid-lowering mechanism by Realtime fluorescent quantitative polymerase chain reaction(q PCR).The results indicated that highland barley extract contains many components with lipid-lowering effects,such as hyperoside and scoparone.In vitro,the lipase assay showed an 18.4%lipase inhibition rate when the additive contents of highland barley extract were 100μg/m L.The intracellular lipid-lowering effect of highland barley extract was examined using 0.25 mmol/L OA-induced HepG2 cells.The results showed that intracellular TG,LDL-C,and T-CHO content decreased by 34.4%,51.2%,and 18.4%,respectively.ALT and AST decreased by 51.6%and 20.7%compared with the untreated hyperlipidemic HepG2 cells.q PCR results showed that highland barley polyphenols could up-regulation the expression of lipid metabolism-related genes such as PPARγand Fabp4. 展开更多
关键词 Highland barley Polyphenols extract Lipid-lowering effect hepg2 cells
下载PDF
Effect of IL-18 on peripheral blood mononuclear cells of chronic hepatitis B and hepatitis B virus DNA released by HepG2.2.15 cell lines 被引量:19
4
作者 Ying Sun, Huan-Yong Chen and Shao-Jie Xin Harbin, China Department of Infectious Diseases, First Clinical Col- lege, Harbin Medical University, Harbin 150001 , China 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2004年第2期230-234,共5页
BACKGROUND: Interleukin-18 (IL-18), a pro-inflamma- tory cytokine that induces interferon-γ (IFN-γ) production in T cells and natural killer cells, plays a critical role in the T-lymphocyte helper type 1 ( Th1) resp... BACKGROUND: Interleukin-18 (IL-18), a pro-inflamma- tory cytokine that induces interferon-γ (IFN-γ) production in T cells and natural killer cells, plays a critical role in the T-lymphocyte helper type 1 ( Th1) response. This study was designed to explore the effect of IL-18 on peripheral blood mononuclear cells ( PBMCs) derived from chronic hepatitis B (CHB) and on hepatitis B virus (HBV) DNA released by HepG2.2.15 cell lines, which were transfected with hepatitis B virus gene in vitro. METHODS: PBMCs isolated from 25 healthy people and 25 patients with CHB were stimulated with HBcAg and IL-18 of various concentrations for 72 hours. The levels of IFN-γ in the supernatants of cultured PBMCs were determined by ELISA. After the stimulation of IL-18 of various concentra- tions, PBMCs derived from one patient were co-cultured for 96 hours with HepG2. 2. 15 cells which had been cul- tured for 24 hours, and then the supernatants were collected by centrifugation and used for HBV DNA quantitative as- say. RESULTS: When PBMCs were stimulated by HBcAg and IL-18 at various concentrations, the levels of IFN-γ in the supernatants of CHB groups were much higher than those in normal control groups, at 0.2 ng/ml: t =11.70, P< 0.01; at 1.0 ng/ml: t =16.19, P<0.01; and at5.0 ng/ml: t =20.12, P <0.01. In the CHB groups, the levels of IFN-γ in the supernatants of PBMCs stimulated by HBcAg alone were lower than both those stimulated by HBcAg and EL-18 at various concentrations and those stimulated by HBcAg and EL-18 (5.0 ng/ml) together with EL-12 (mild: t = 2.20, P<0.05; moderate; t=2.97, P<0.05; severe; t = 0.66, P >0.05). The content of HBV DNA in the superna- tant of co-cultivation of HepG2. 2. 15 cells and PBMCs without stimulated materials was higher than that stimula-ted by HBcAg and EL-18 at various concentrations of HBc- Ag and IL-18 together with IL-12/IFN-α1lb. CONCLUSION: DL-18 can induce IFN-γ secretion and pro- bably play a key role in the modulation of both innate and adaptive immunity. It has implications in improving im- munoregulatory effect and increasing the ability of immune cells to kill cells infected by virus. 展开更多
关键词 INTERLEUKIN-18 chronic hepatitis B peripheral blood mononuclear cells HepG2.2.15 cells INTERFERON-Γ HBV DNA
下载PDF
Combination of small interfering RNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cells 被引量:10
5
作者 Xiao-Min Xin Gui-Qiu Li +2 位作者 Ying-Yu Jin Min Zhuang Di Li 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第24期3849-3854,共6页
AIM: To observe the inhibition of hepatitis B virus (HBV) replication and expression in HepG2.2.15 cells by combination of small interfering RNAs (siRNAs). METHODS: Recombinant plasmid psiI-HBV was constructed a... AIM: To observe the inhibition of hepatitis B virus (HBV) replication and expression in HepG2.2.15 cells by combination of small interfering RNAs (siRNAs). METHODS: Recombinant plasmid psiI-HBV was constructed and transfected into HepG2.2.15 cells. At 48 h, 72 h and 96 h after transfection, culture media were collected and cells were harvested for HBV replication assay. HBsAg and HBeAg in the cell culture medium were detected by enzyme-linked immunoadsorbent assay (ELISA). Intracellular viral DNA and covalently closed circular DNA (cccDNA) were quantified by real-time polymerase chain reaction (PCR). HBV viral mRNA was reverse transcribed and quantified by reverse-transcript PCR (RT-PCR). RESULTS: siRNAs showed marked anti-HBV effects. siRNAs could specifically inhibit the expression of HBsAg and the replication of HBV DNA in a dosedependent manner. Furthermore, combination of siRNAs, compared with individual use of each siRNA, exerted a stronger inhibition on antigen expression and viral replication. More importantlycombination of siRNAs significantly suppressed HBV cccDNA amplification. CONCLUSION: Combination of siRNAs mediates a stronger inhibition on viral replication and antigenexpression in HepG2.2.15 cells, especially on cccDNA amplification. 展开更多
关键词 Combination of small interfering RNAs Covalently closed circular DNA Hepatitis B virus RNA interference HepG2.2.15 cells
下载PDF
Reduction of the oxidative damage to H_(2)O_(2)-induced HepG2 cells via the Nrf2 signalling pathway by plant flavonoids Quercetin and Hyperoside
6
作者 Meijing Zhang Gaoshuai Zhang +10 位作者 Xiangxing Meng Xinxin Wang Jiao Xie Shaoshu Wang Biao Wang Jilite Wang Suwen Liu Qun Huang Xu Yang Jing Li Hao Wang 《Food Science and Human Wellness》 SCIE CAS CSCD 2024年第4期1864-1876,共13页
Hyperoside and quercetin are similar in molecular structures.In this study,the antioxidant regulatory targets of hyperoside and quercetin are mainly in the nuclear factor(erythroid-2-derived)-related factor 2(Nrf2)pat... Hyperoside and quercetin are similar in molecular structures.In this study,the antioxidant regulatory targets of hyperoside and quercetin are mainly in the nuclear factor(erythroid-2-derived)-related factor 2(Nrf2)pathway predicted by network pharmacology.And the antioxidant effect and mechanism of hyperoside and quercetin were measured and compared in H_(2)O_(2)-induced Hep G2 cells and Caenorhabditis elegans.The findings indicated that quercetin was more effective than hyperoside in reducing oxidative damage,which was proved by improved cell viability,decreased reactive oxygen species(ROS)production,decreased cellular apoptosis,and alleviated mitochondrial damage.In addition,quercetin was more efficient than hyperoside in enhancing the expression of Nrf2-associated m RNAs,increasing the activities of superoxide dismutase(SOD),glutathione peroxidase(GSH-Px),and catalase(CAT),and reducing the cellular malondialdehyde(MDA)content.Quercetin was superior to hyperoside in prolonging the lifespan of worms,decreasing the accumulation of lipofuscin,inhibiting ROS production,and increasing the proportion of skn-1 in the nucleus.With the Nrf2 inhibitor ML385,we verified that quercetin and hyperoside primarily protected the cells against oxidative damage via the Nrf2 signalling pathway.Furthermore,molecular docking and dynamics simulations demonstrated that the quercetin-Kelch-like ECH-associated protein 1(Keap1)complex was more stable than the hyperoside-Keap1 complex.The stable structure of the complex might hinder the binding of Nrf2 and Keap1 to release Nrf2 and facilitate its entry into the nucleus to play an antioxidant role.Overall,quercetin had a better antioxidant than hyperoside. 展开更多
关键词 HYPEROSIDE QUERCETIN hepg2 cell Oxidative damage Nrf2 signalling pathway
下载PDF
Polysaccharide-rich extract of Potentilla anserina ameliorates nonalcoholic fatty liver disease in free fatty acid-induced HepG2 cells and high-fat/sugar diet-fed mice
7
作者 Xiujun Lin Yimei Zheng +6 位作者 Yingying Yan Hongting Deng Shunxin Wang Yuanju He Yuting Tian Wenhui Zhang Hui Teng 《Food Science and Human Wellness》 SCIE CAS CSCD 2024年第6期3351-3360,共10页
Potentilla anserina L.(PA)belongs to the Rosaceae family,is a common edible plant in the Qinghai-Tibet Plateau areas of China.This study elucidates the mechanism upon which crude polysaccharide of PA(PAP)on fat accumu... Potentilla anserina L.(PA)belongs to the Rosaceae family,is a common edible plant in the Qinghai-Tibet Plateau areas of China.This study elucidates the mechanism upon which crude polysaccharide of PA(PAP)on fat accumulation in HepG2 cells stimulated by oleic acid(OA)and high fat high sugar induced mice.The result revealed that PAP inhibited lipid accumulation in obese mice and ameliorated the degree of damage in OA-induced HepG2 cells.Specifically,compared to the control group,the TG and TC levels were decreased in cells and mice serum,the aspartate transaminase and alamine aminotransferase contents were declined in liver of obese mice by PAP treatment.The expressions of adipogenic genes of SREBP-1c,C/EBPα,PPARγ,and FAS were inhibited after PAP treatment.Moreover,PAP increased the mRNA levels of CPT-1 and PPARα,which were involved in fatty acid oxidation.The present results indicated the PAP could alleviate the damage of liver associated with obesity and PAP treatment might provide a dietary therapeutic option for the treatment of hyperlipidemia. 展开更多
关键词 Potentilla anserina L. Non-alcoholic fatty liver disease Lipid accumulation hepg2 cells High fat diet
下载PDF
Interleukin-10 Is Expressed in HepG2.2.15 Cells and Regulated by STAT1 Pathway 被引量:1
8
作者 刘敏 郝友华 +2 位作者 丁红晖 杨东亮 陆蒙吉 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2011年第5期625-631,共7页
This study investigated the expression profiles of IL-10 gene in three human hepatoma cell lines including Huh7, HepG2, and HepG2 transfected with a plasmid containing hepatitis B virus (HBV) named HepG2.2.15. RT-PC... This study investigated the expression profiles of IL-10 gene in three human hepatoma cell lines including Huh7, HepG2, and HepG2 transfected with a plasmid containing hepatitis B virus (HBV) named HepG2.2.15. RT-PCR analysis demonstrated that IL-10 message RNA was absent in HepG2 and Huh7 cells, whereas it was present in HepG2.2.15 cells, which was consistent with ELISA result. Furthermore, except for lamivudine other antiviral treatments did not significantly decrease the HBV DNA level in HepG2.2.15 cells, while they had different effects on the expression of IL-10 protein, although stimulation by LPS had no significant effect. In addition, except for poly(I:C), the other treatments decreased the expression of IL-10 protein to different degrees, but had no sig-nificant effects on the expression of NF-κB and MyD88. Meanwhile, all treatments we used had effect on the expression of STAT1. In conclusion, IL-10 was expressed in HepG2.2.15 cells and STAT1 pathway might be involved in the regulation of IL-10 expression in HepG2.2.15 cells, but it was not the sole pathway, the exact mechanism warrants further study. 展开更多
关键词 hepatoma cell INTERLEUKIN-10 hepatitis B virus HEPATOCYTE HEPG2.2.15
下载PDF
荔枝核提取物对HepG2.2.15细胞系HBsAg与HBeAg表达的影响 被引量:36
9
作者 徐庆 陈全斌 +1 位作者 义祥辉 陈重阳 《中国医院药学杂志》 CAS CSCD 北大核心 2004年第7期393-395,共3页
目的 :研究荔枝核对乙型肝炎病毒的抑制作用及其有效部位。方法 :应用HepG 2 .2 .15细胞系培养系统检测荔枝核提取物A、B、C、D、E、F对HBsAg与HbeAg表达的影响。 结果 :荔枝核提取物A、B、C、D、E、F (2 0 0 ,10 0mg·L-1)对HBsAg... 目的 :研究荔枝核对乙型肝炎病毒的抑制作用及其有效部位。方法 :应用HepG 2 .2 .15细胞系培养系统检测荔枝核提取物A、B、C、D、E、F对HBsAg与HbeAg表达的影响。 结果 :荔枝核提取物A、B、C、D、E、F (2 0 0 ,10 0mg·L-1)对HBsAg和HbeAg表达均有抑制作用 ,其中E成分作用最强 ,在 2 0 0mg·L-1的浓度下 ,于实验第 3天对HBsAg的抑制率为 5 0 % ,对HBeAg的抑制率为 2 0 % ,于实验第 9天对HBsAg的抑制率为90 .9% ,对HBeAg的抑制率为84 .3% (与对照组比较P <0 .0 1)。结论 :荔枝核提取物体外有较强的抗乙肝病毒作用。 展开更多
关键词 荔枝核 HEPG 2.2.15细胞 HBSAG HBeAg
下载PDF
青钱柳提取物对HepG2 2.2.15细胞HBsAg和HBeAg表达的影响 被引量:5
10
作者 韦京辰 杨新平 +2 位作者 李俊 何松青 徐庆 《中成药》 CAS CSCD 北大核心 2012年第7期1220-1224,共5页
目的研究青钱柳提取物体外抗乙肝病毒作用。方法青钱柳用75%乙醇提取后按溶剂极性萃取,获得的三氯甲烷部位经柱层析得到Fr.2组分。体外培养HepG2 2.2.15细胞,MTT法检测青钱柳提取物Fr.2组分对HepG22.2.15细胞的细胞毒作用,用ELISA法检测... 目的研究青钱柳提取物体外抗乙肝病毒作用。方法青钱柳用75%乙醇提取后按溶剂极性萃取,获得的三氯甲烷部位经柱层析得到Fr.2组分。体外培养HepG2 2.2.15细胞,MTT法检测青钱柳提取物Fr.2组分对HepG22.2.15细胞的细胞毒作用,用ELISA法检测HepG2 2.2.15细胞培养液中HBsAg和HBeAg的表达。结果青钱柳提取物Fr.2组分对HepG2 2.2.15细胞无明显的细胞毒作用。与对照组比较,Fr.2组分对HBsAg和HBeAg的表达均有显著性抑制作用(P<0.01或0.05)。结论青钱柳提取物体外具有较强的抗乙肝病毒作用。 展开更多
关键词 青钱柳 hepg2 2.2.15细胞 HBSAG HBEAG
下载PDF
甘草甜素对HBsAg低表达HepG2.2.15细胞株HBV感染及TLR2、4的影响 被引量:5
11
作者 李永伟 杨宏志 +2 位作者 柯千山 陈伟 陈雪娟 《中药材》 CAS CSCD 北大核心 2008年第3期403-407,共5页
目的:探讨甘草甜素(GL)对HepG2.2.15细胞上清HBV DNA、e抗原分泌,Toll样受体2、4(TLR2、4)信号分子的表达及对细胞增殖的影响。方法:实时荧光定量PCR检测HBV DNA表达,ELISA检测HBV所分泌抗原,MTT检测细胞增殖活性,直接免疫荧光流式细胞... 目的:探讨甘草甜素(GL)对HepG2.2.15细胞上清HBV DNA、e抗原分泌,Toll样受体2、4(TLR2、4)信号分子的表达及对细胞增殖的影响。方法:实时荧光定量PCR检测HBV DNA表达,ELISA检测HBV所分泌抗原,MTT检测细胞增殖活性,直接免疫荧光流式细胞术(FCM)检测TLR2、4在细胞株上表达的阳性细胞率,并与空白对照组对比。结果:HBsAg在该细胞株低表达,但HBeAg则明显阳性,因此研究了GL对e抗原的影响,给药后第3d e抗原总体均数间差异显著(P<0.01),但只有400μg/ml组与对照组间比较显著降低(P<0.05),800μg/ml组则较其余GL组明显升高(P<0.01)。HBV DNA给药后第3 d总体均数间比较差异有显著性,只有50μg/ml组较对照组降低,但无统计学意义(P>0.05),其余各组均较对照组升高;各组TLR2、4数值总体均数间有显著差异(P<0.01)。除200μg/ml组外,各剂量组与对照组比较显示两者均显著上调(P<0.05),但均无剂量依赖关系;MTT实验显示200μg/ml以下三个剂量组均可促进细胞增殖,但只有200μg/ml组与对照组间差异显著(P<0.05);400、800μg/ml两组均显著抑制细胞增殖(P<0.01);而MTT分别与HBeAg、HBV DNA呈显著负相关(P<0.05)。结论:研究表明,GL对HepG2.2.15变异株的病毒复制及e抗原分泌可能具有双向作用;细胞的存活数与病毒复制及e抗原呈负相关;TLR2在变异株低表达,GL呈非剂量依赖关系上调TLR2、4表达,至少在该细胞株GL影响HBV的机理与TLR2、4信号的改变无关,但有可能在体内通过免疫途径影响HBV。 展开更多
关键词 甘草甜素 HBV Toll样受体2、4 HEPG2.2.15细胞株
下载PDF
复方六月雪对HepG2.2.15细胞HBsAg和HBeAg的抑制作用 被引量:17
12
作者 张士军 黄春喜 +2 位作者 谢海源 黄仁彬 林军 《中国医院药学杂志》 CAS CSCD 北大核心 2007年第6期715-717,共3页
目的:观察复方六月雪(CLYX)体外抗乙型肝炎病毒(HBV)的作用。方法:采用四甲基噻唑蓝(MTT)法检测CLYX对HepG2.2.15细胞的半数毒性浓度(TC50)和最大无毒浓度(TC0);在TC0基础上观察不同浓度药物作用于HepG2.2.15细胞,分别在第72h和144h收... 目的:观察复方六月雪(CLYX)体外抗乙型肝炎病毒(HBV)的作用。方法:采用四甲基噻唑蓝(MTT)法检测CLYX对HepG2.2.15细胞的半数毒性浓度(TC50)和最大无毒浓度(TC0);在TC0基础上观察不同浓度药物作用于HepG2.2.15细胞,分别在第72h和144h收集细胞培养上清液,采用酶联免疫吸附实验(ELISA)法测定上清液HBsAg和HBeAg的滴度。结果:TC50为3.070g·L-1,TC0为0.945g·L-1,复方六月雪对HepG2.2.15细胞毒性较低。无毒浓度的复方六月雪在HepG2.2.15细胞培养中可有效地抑制细胞HBsAg(乙型肝炎表面抗原)和HBeAg(乙型肝炎E抗原)的分泌;且治疗指数(TI)均大于2,为高效低毒的抗HBV药物。结论:CLYX在体外有显著的抗HBV的作用,且毒性较低。 展开更多
关键词 复方六月雪 HepG2.2.15细胞培养 HBsAg HBeAg
下载PDF
恩替卡韦和干扰素序贯作用对HepG2.2.15细胞HBV DNA复制的影响 被引量:3
13
作者 杨伟 赵超 +2 位作者 李婧 丁扬 王雪 《胃肠病学和肝病学杂志》 CAS 2016年第4期408-410,共3页
目的探讨恩替卡韦(Entecavir,ETV)与干扰素(IFNα-2b)序贯作用对Hep G2.2.15细胞HBV DNA复制的影响。方法将培养Hep G2.2.15细胞分组,单独组中分别加入不同浓度ETV的配制液(1.5μg/ml、5μg/ml、10μg/ml)或IFNα-2b配制液(5 000 IU/ml... 目的探讨恩替卡韦(Entecavir,ETV)与干扰素(IFNα-2b)序贯作用对Hep G2.2.15细胞HBV DNA复制的影响。方法将培养Hep G2.2.15细胞分组,单独组中分别加入不同浓度ETV的配制液(1.5μg/ml、5μg/ml、10μg/ml)或IFNα-2b配制液(5 000 IU/ml、10 000 IU/ml、15 000 IU/ml);联合组中联合加入ETV和IFNα-2b配制液;序贯组中先后加入ETV和IFNα-2b序贯配制液。在不同时点,采用MTT法检测Hep G2.2.15细胞增殖情况,采用实时荧光定量法检测各组细胞培养上清液中HBV DNA水平,酶联免疫法(ELISA)检测上清液中HBs Ag与HBe Ag水平。结果随着时间延长,序贯组对Hep G2.2.15的HBV DNA复制抑制作用明显大于其他两组(P<0.05);对HBs Ag与HBe Ag的抑制作用随时间的延长而加强(P<0.05)。结论 ETV与IFNα-2b序贯作用于Hep G2.2.15细胞,对Hep G2.2.15细胞HBV DNA复制有明显的抑制作用,且作用强于单独或联合使用。 展开更多
关键词 恩替卡韦 干扰素Α-2B HEPG2.2.15细胞 HBV DNA 序贯作用
下载PDF
基因芯片筛选HepG2与HepG2.2.15细胞中的差异表达基因 被引量:2
14
作者 汤玉瑜 陈永文 +1 位作者 费蕾 吴玉章 《免疫学杂志》 CAS CSCD 北大核心 2008年第3期329-331,336,共4页
目的探讨HepG2细胞及HepG2.2.15细胞中差异表达的基因并对其基因表达谱进行生物学信息分析。方法用Trizol一步法提取HepG2细胞及HepG2.2.15细胞的总RNA,并纯化mRNA,反转录合成荧光分子(Cy3/Cy5)标记的cD-NA探针,与基因芯片杂交;采用LuxS... 目的探讨HepG2细胞及HepG2.2.15细胞中差异表达的基因并对其基因表达谱进行生物学信息分析。方法用Trizol一步法提取HepG2细胞及HepG2.2.15细胞的总RNA,并纯化mRNA,反转录合成荧光分子(Cy3/Cy5)标记的cD-NA探针,与基因芯片杂交;采用LuxScan3.0图像分析软件对芯片图像进行分析,把图像信号转化为数字信号,最后以差异为2倍的标准来确定差异表达基因。结果在54614个基因表达谱的筛选中,发现有4462个基因表达水平显著上调,2592个基因表达水平显著下调。结论HBV基因组及其表达产物对于肝细胞基因表达谱有显著影响,可能参与了肝癌的发生发展。 展开更多
关键词 基因芯片 差异表达 hepg2细胞 HEPG2.2.15细胞
下载PDF
甘草甜素对HepG2.2.15细胞株HBeAg水平及TLR4表达的影响 被引量:1
15
作者 李永伟 杨宏志 +2 位作者 郭云蔚 陆慧琼 凌小强 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第4期544-547,共4页
目的探讨甘草甜素(GL)对HepG2.2.15细胞上清HBeAg分泌,Toll样受体4(TLR4)信号分子的表达及对细胞增殖的影响。方法实时荧光定量PCR检测TLR4表达;直接免疫荧光流式细胞术(FCM)检测表达TLR4的阳性细胞率;ELASA检测HBV所分泌抗原;MTT检测... 目的探讨甘草甜素(GL)对HepG2.2.15细胞上清HBeAg分泌,Toll样受体4(TLR4)信号分子的表达及对细胞增殖的影响。方法实时荧光定量PCR检测TLR4表达;直接免疫荧光流式细胞术(FCM)检测表达TLR4的阳性细胞率;ELASA检测HBV所分泌抗原;MTT检测细胞增殖活性,并与空白对照组比较。结果给药后HBVe抗原(HBeAg)的分泌结果显示,总体均数间差异显著(P<0.05),但甘草甜素各组与对照组比较差异无统计学意义;GL各组TLR4 mRNA及流式细胞TLR4的表达总体均数间均有显著差异(P<0.01),分别与对照组相比差异有显著性(P<0.01),100μg/mL组尤其明显;MTT实验显示,200μg/mL以下三个剂量组均可促进细胞增殖,50μg/mL组与对照组间差异显著(P<0.05);400μg/mL、800μg/mL两组均显著抑制细胞增殖(P<0.01);而MTT结果与HBeAg水平呈显著负相关(P<0.01),与TLR4表达无相关关系(P>0.05)。结论研究表明,甘草甜素对HepG2.2.15的e抗原分泌可能具有双向作用;细胞的存活率与e抗原呈负相关;TLR4在HepG2.2.15细胞株低表达,GL可上调TLR4表达,甘草甜素可影响先天免疫中的TLR4信号分子,有可能在体内通过免疫途径影响HBV复制和抗原分泌。 展开更多
关键词 甘草甜素 HBV TOLL样受体4 HEPG2.2.15细胞株
下载PDF
慢病毒介导的shRNA干扰人HepG2.2.15细胞Akt2基因表达的研究 被引量:1
16
作者 刘洋 芦琳琳 +2 位作者 杜水仙 宣世英 辛永宁 《中国肝脏病杂志(电子版)》 CAS 2016年第2期72-76,共5页
目的针对Akt2基因构建shRNA慢病毒干扰载体并评价慢病毒介导的RNA干扰在人HepG2.2.15中的基因沉默效应。方法设计Akt2的RNAi寡聚核苷酸序列,利用慢病毒载体构建Akt2的shRNA载体,转染入大肠埃希菌并观察重组表达状况,利用293T细胞包装得... 目的针对Akt2基因构建shRNA慢病毒干扰载体并评价慢病毒介导的RNA干扰在人HepG2.2.15中的基因沉默效应。方法设计Akt2的RNAi寡聚核苷酸序列,利用慢病毒载体构建Akt2的shRNA载体,转染入大肠埃希菌并观察重组表达状况,利用293T细胞包装得到重组腺病毒,以绿色荧光蛋白(GFP)作为标记,逐孔稀释法确定转染效率及滴度,以实时荧光定量法比较各组对Akt2 mRNA的干扰效果。结果筛选了所构建的3个Akt2靶向序列,包装shRNA慢病毒后转染HepG2.2.15细胞,慢病毒转染后的沉默效率可达85%,比较得出沉默效率最高的靶序列和工作条件。结论本研究成功构建并筛选了针对Akt2的shRNA慢病毒载体,有效抑制HepG2.2.15细胞中Akt2 mRNA的表达。 展开更多
关键词 AKT2 SHRNA 慢病毒 HEPG2.2.15
下载PDF
干扰素对HepG2.2.15细胞表达HBVM及p53蛋白影响的实验研究 被引量:2
17
作者 张国英 梁晋汾 《长治医学院学报》 2004年第1期5-7,共3页
目的 :观察α - 2b干扰素对细胞培养上清中HBsAg和HBeAg、HBV -DNA水平和对p5 3蛋白的影响作用。方法 :分别用酶联免疫吸附实验和荧光定量PCR法测定培养HepG2 .2 .1 5细胞悬浮液中HBV -DNA ,HBsAg和HBeAg含量变化 ;免疫组化法观察p5 3... 目的 :观察α - 2b干扰素对细胞培养上清中HBsAg和HBeAg、HBV -DNA水平和对p5 3蛋白的影响作用。方法 :分别用酶联免疫吸附实验和荧光定量PCR法测定培养HepG2 .2 .1 5细胞悬浮液中HBV -DNA ,HBsAg和HBeAg含量变化 ;免疫组化法观察p5 3蛋白在培养细胞中的含量和分布 ;计算α -2b干扰素对HBV及相关抗原的抑制率。结果 :α - 2b干扰素在 1 0 0 0IU/mL - 5 0 0 0IU/mL浓度范围内呈剂量相关性抑制。当浓度达 30 0 0IU/mL ,作用至第 5d时 ,对HBsAg和HBeAg的抑制率分别达 89.32 %、87.2 3%和 82 .66%,并趋于稳定。免疫组化染色 ,治疗组p5 3蛋白颗粒增多 ,与细胞核相联 ,胞浆颗粒稀少。结论 :α - 2b干扰素可抑制HepG2 .2 .1 5细胞分泌HBsAg、HBeAg、HBV -DNA ,并能影响p5 3蛋白的表达和分布 ,提示α - 展开更多
关键词 乙型肝炎病毒 HEPG2.2.15细胞 Α-2B干扰素 P53蛋白
下载PDF
人肝癌细胞系HepG2与HepG2.2.15差异HLA结合肽的分离与鉴定 被引量:1
18
作者 陈黎 谢兴旺 +4 位作者 张恒辉 费然 丛旭 魏来 陈红松 《世界华人消化杂志》 CAS 北大核心 2008年第21期2343-2348,共6页
目的:分离并鉴定整合表达HBV的人肝癌细胞系HepG2.2.15及其母细胞系HepG2的差异HLAⅠ类分子结合肽,寻找与HBV感染相关的HLA结合肽.方法:洗涤法得到HepG2和HepG2.2.15细胞表面的HLAⅠ类分子及与其结合的肽段.效液相色谱(HPLC)对两种细胞... 目的:分离并鉴定整合表达HBV的人肝癌细胞系HepG2.2.15及其母细胞系HepG2的差异HLAⅠ类分子结合肽,寻找与HBV感染相关的HLA结合肽.方法:洗涤法得到HepG2和HepG2.2.15细胞表面的HLAⅠ类分子及与其结合的肽段.效液相色谱(HPLC)对两种细胞的洗脱肽段进行分离和图谱比较,挑选出HepG2.2.15特有的峰段进行纳升电喷雾串联质谱(nano ESI-MS/MS)分析,结合MASCOT数据库检索和从头测序,分析多肽的序列和来源.后采用RT-PCR法进行mRNA表达检测.结果:HPLC对比显示HepG2和HepG2.2.15的HLA结合肽存在显著差异.利用nanoESI-MS/MS技术从HPLC差异峰段中分离鉴定出一条来源于已知蛋白人烯醇酶-1(enolase1,ENO1)的多肽SPDDPSRYISPDQ.RT-PCR结果显示,ENO1在HepG2和HepG2.2.15细胞中均有表达,且在HepG2.2.15细胞中表达明显高于HepG2细胞.结论:来自ENO1的多肽SPDDPSRYISPDQ能够被HLAⅠ类分子提呈到HepG2.2.15细胞表面,且ENO1 mRNA在HepG2.2.15细胞中的表达显著高于HepG2细胞.提示HBV感染可能引起ENO1表达上调. 展开更多
关键词 hepg2细胞 HEPG2.2.15细胞 乙型肝炎病毒 烯醇酶-1 高效液相色谱 质谱
下载PDF
针对HBV preS1、preS2编码链的反基因锁核酸对HepG2.2.15细胞的抗病毒效果 被引量:4
19
作者 彭彬 许桂丹 +4 位作者 韦武均 农顺强 陈晓昊 肖树荣 邓益斌 《检验医学与临床》 CAS 2020年第21期3106-3109,共4页
目的探讨乙型肝炎病毒(HBV)preS1、preS2 DNA同聚嘌呤区设计的锁核酸在体外对HBV复制和表达的抑制作用。方法设计并合成锁核酸,以Lipo3000作为载体转染至锁核酸-脂质体组,设空白对照组,运用荧光定量PCR、化学发光免疫分析等技术观察锁... 目的探讨乙型肝炎病毒(HBV)preS1、preS2 DNA同聚嘌呤区设计的锁核酸在体外对HBV复制和表达的抑制作用。方法设计并合成锁核酸,以Lipo3000作为载体转染至锁核酸-脂质体组,设空白对照组,运用荧光定量PCR、化学发光免疫分析等技术观察锁核酸对HBsAg表达、HBV DNA复制的抑制作用,采用CCK8比色法观察锁核酸对HepG2.2.15细胞基本代谢的影响。结果加入锁核酸后,HBsAg、HBV DNA表达量相对于空白对照组逐渐降低,并随时间呈递增趋势,其中,preS1的3023-3037nt位点在第9天对HBsAg表达的抑制率达(61.94±4.11)%,对HBV DNA复制的抑制率达(56.08±3.22)%;preS2的3305-3320nt位点在第9天对HBsAg表达的抑制率达(72.93±4.14)%,对HBV-DNA复制的抑制率达(61.79±3.40)%。结论HBV preS1编码链的3023-3037nt位点和preS2编码链的3305-3320nt位点的反基因锁核酸片段对HBsAg表达和HBV-DNA复制的抑制效果最为明显,两者均可以作为抗HBV治疗的有效靶位。 展开更多
关键词 乙型肝炎病毒 锁核酸 PRES1 PRES2 HEPG2.2.15细胞
下载PDF
Partial Beclin 1 silencing aggravates doxorubicin-and Fasinduced apoptosis in HepG2 cells 被引量:11
20
作者 Fanny Daniel Agnès Legrand +3 位作者 Dominique Pessayre Nathalie Vadrot Véronique Descatoire Dominique Bernuau 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第18期2895-2900,共6页
AIM: To investigate the role of Beclin 1 on the susceptibility of HepG2 cells to undergo apoptosis after anti-Fas antibody or doxorubicin treatment. METHODS: Beclin 1 silencing was achieved using RNA interference. D... AIM: To investigate the role of Beclin 1 on the susceptibility of HepG2 cells to undergo apoptosis after anti-Fas antibody or doxorubicin treatment. METHODS: Beclin 1 silencing was achieved using RNA interference. DNA ploidy, the percentage of apoptotic cells and the mitochondrial membrane potential were assessed by flow cytometry. Levels of Beclin 1, BCI-XL and cytochrome c, and the cleavage of poly (ADP-ribose) polymerase (PARP) were assayed by using Western blots. RESULTS: Beclin 1 expression decreased by 75% 72 h after Beclin 1 siRNA transfection. Partial Beclin 1 silencing significantly increased the percentage of subG1 cells 24 and 40 h after treatment with doxorubicin or anti-Fas antibody, respectively, and this potentiation was abrogated by treatment with a pan-caspase inhibitor. Partial Beclin 1 silencing also increased PARP cleavage, mitochondrial membrane depolarization and cytosolic cytochrome c. The pro-apoptotic consequences of partial Beclin 1 silencing were not associated with a decline in Bcl-XL expression.CONCLUSION: Partial Beclin 1 silencing aggravates mitochondrial permeabilization and apoptosis in HepG2 cells treated with an anti-Fas antibody or with doxorubicin. 展开更多
关键词 Beclin 1 Apoptosis hepg2 cells Anti-Fas antibody DOXORUBICIN
下载PDF
上一页 1 2 17 下一页 到第
使用帮助 返回顶部